Oncology – Spine

RCT: Observation vs. screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases.

16 Mar, 2022 | 08:26h | UTC

Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial – The Lancet Oncology

 

Commentary on Twitter

In @LancetOncology : Brilliant question answered by this RCT?Any role of screening for malignant spinal cord compression & pre-emptive Rx in asymptomatic mCRPC #prostatecancer ? Answer is "NO". Congrats to @DearnaleyProf & team Free access: https://t.co/8r4yJOYCLA @OncoAlert pic.twitter.com/8oLIwKKOx1

— Neeraj Agarwal (@neerajaiims) March 12, 2022

 

---

Randomized Trial: Single-Fraction vs. Multifraction Radiotherapy for Spinal Canal Compression from Metastatic Cancer

4 Dec, 2019 | 08:18h | UTC

Effect of Single-Fraction vs Multifraction Radiotherapy on Ambulatory Status Among Patients With Spinal Canal Compression From Metastatic Cancer: The SCORAD Randomized Clinical Trial – JAMA (free for a limited period)

Commentary: One dose of radiotherapy as effective as five doses for cancer in the spine – University College London (free)

 

---